Functional differences in epigenetic modulators - Superiority of mercaptoacetamide-based histone deacetylase inhibitors relative to hydroxamates in cortical neuron neuroprotection studies

Alan P. Kozikowski, Yufeng Chen, Arsen Gaysin, Bin Chen, Melissa A. D'Annibale, Carla M. Suto, Brett C. Langley

Research output: Contribution to journalArticle

Abstract

We compare the ability of two structurally different classes of epigenetic modulators, namely, histone deacetylase (HDAC) inhibitors containing either a hydroxamate or a mercaptoacetamide as the zinc binding group, to protect cortical neurons in culture from oxidative stress-induced death. This study reveals that some of the mercaptoacetamide-based HDAC inhibitors are fully protective, whereas the hydroxamates show toxicity at higher concentrations. Our present results appear to be consistent with the possibility that the mercaptoacetamide-based HDAC inhibitors interact with a different subset of the HDAC isozymes [less activity at HDAC1 and 2 correlates with less inhibitor toxicity], or alternatively, are interacting selectively with only the cytoplasmic HDACs that are crucial for protection from oxidative stress.

Original languageEnglish (US)
Pages (from-to)3054-3061
Number of pages8
JournalJournal of Medicinal Chemistry
Volume50
Issue number13
DOIs
StatePublished - Jun 28 2007
Externally publishedYes

Fingerprint

Histone Deacetylase Inhibitors
Epigenomics
Modulators
Neurons
Oxidative stress
Toxicity
Oxidative Stress
Histone Deacetylases
Isoenzymes
Zinc
Neuroprotection

ASJC Scopus subject areas

  • Organic Chemistry

Cite this

Functional differences in epigenetic modulators - Superiority of mercaptoacetamide-based histone deacetylase inhibitors relative to hydroxamates in cortical neuron neuroprotection studies. / Kozikowski, Alan P.; Chen, Yufeng; Gaysin, Arsen; Chen, Bin; D'Annibale, Melissa A.; Suto, Carla M.; Langley, Brett C.

In: Journal of Medicinal Chemistry, Vol. 50, No. 13, 28.06.2007, p. 3054-3061.

Research output: Contribution to journalArticle

Kozikowski, Alan P. ; Chen, Yufeng ; Gaysin, Arsen ; Chen, Bin ; D'Annibale, Melissa A. ; Suto, Carla M. ; Langley, Brett C. / Functional differences in epigenetic modulators - Superiority of mercaptoacetamide-based histone deacetylase inhibitors relative to hydroxamates in cortical neuron neuroprotection studies. In: Journal of Medicinal Chemistry. 2007 ; Vol. 50, No. 13. pp. 3054-3061.
@article{fc69e84b69f0491eb726909e160a68bb,
title = "Functional differences in epigenetic modulators - Superiority of mercaptoacetamide-based histone deacetylase inhibitors relative to hydroxamates in cortical neuron neuroprotection studies",
abstract = "We compare the ability of two structurally different classes of epigenetic modulators, namely, histone deacetylase (HDAC) inhibitors containing either a hydroxamate or a mercaptoacetamide as the zinc binding group, to protect cortical neurons in culture from oxidative stress-induced death. This study reveals that some of the mercaptoacetamide-based HDAC inhibitors are fully protective, whereas the hydroxamates show toxicity at higher concentrations. Our present results appear to be consistent with the possibility that the mercaptoacetamide-based HDAC inhibitors interact with a different subset of the HDAC isozymes [less activity at HDAC1 and 2 correlates with less inhibitor toxicity], or alternatively, are interacting selectively with only the cytoplasmic HDACs that are crucial for protection from oxidative stress.",
author = "Kozikowski, {Alan P.} and Yufeng Chen and Arsen Gaysin and Bin Chen and D'Annibale, {Melissa A.} and Suto, {Carla M.} and Langley, {Brett C.}",
year = "2007",
month = "6",
day = "28",
doi = "10.1021/jm070178x",
language = "English (US)",
volume = "50",
pages = "3054--3061",
journal = "Journal of Medicinal Chemistry",
issn = "0022-2623",
publisher = "American Chemical Society",
number = "13",

}

TY - JOUR

T1 - Functional differences in epigenetic modulators - Superiority of mercaptoacetamide-based histone deacetylase inhibitors relative to hydroxamates in cortical neuron neuroprotection studies

AU - Kozikowski, Alan P.

AU - Chen, Yufeng

AU - Gaysin, Arsen

AU - Chen, Bin

AU - D'Annibale, Melissa A.

AU - Suto, Carla M.

AU - Langley, Brett C.

PY - 2007/6/28

Y1 - 2007/6/28

N2 - We compare the ability of two structurally different classes of epigenetic modulators, namely, histone deacetylase (HDAC) inhibitors containing either a hydroxamate or a mercaptoacetamide as the zinc binding group, to protect cortical neurons in culture from oxidative stress-induced death. This study reveals that some of the mercaptoacetamide-based HDAC inhibitors are fully protective, whereas the hydroxamates show toxicity at higher concentrations. Our present results appear to be consistent with the possibility that the mercaptoacetamide-based HDAC inhibitors interact with a different subset of the HDAC isozymes [less activity at HDAC1 and 2 correlates with less inhibitor toxicity], or alternatively, are interacting selectively with only the cytoplasmic HDACs that are crucial for protection from oxidative stress.

AB - We compare the ability of two structurally different classes of epigenetic modulators, namely, histone deacetylase (HDAC) inhibitors containing either a hydroxamate or a mercaptoacetamide as the zinc binding group, to protect cortical neurons in culture from oxidative stress-induced death. This study reveals that some of the mercaptoacetamide-based HDAC inhibitors are fully protective, whereas the hydroxamates show toxicity at higher concentrations. Our present results appear to be consistent with the possibility that the mercaptoacetamide-based HDAC inhibitors interact with a different subset of the HDAC isozymes [less activity at HDAC1 and 2 correlates with less inhibitor toxicity], or alternatively, are interacting selectively with only the cytoplasmic HDACs that are crucial for protection from oxidative stress.

UR - http://www.scopus.com/inward/record.url?scp=34347224016&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34347224016&partnerID=8YFLogxK

U2 - 10.1021/jm070178x

DO - 10.1021/jm070178x

M3 - Article

C2 - 17539623

AN - SCOPUS:34347224016

VL - 50

SP - 3054

EP - 3061

JO - Journal of Medicinal Chemistry

JF - Journal of Medicinal Chemistry

SN - 0022-2623

IS - 13

ER -